{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:27:08Z","timestamp":1772465228608,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68970-8","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:25:05Z","timestamp":1769621105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of a smart pillbox intervention for adherence to oral HIV pre-exposure prophylaxis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7169-7721","authenticated-orcid":false,"given":"Zhen-Hao","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6398-2107","authenticated-orcid":false,"given":"Zhen-Xing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8676-7323","authenticated-orcid":false,"given":"Yi-Ling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-3971","authenticated-orcid":false,"given":"Yong-Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-8943","authenticated-orcid":false,"given":"Hong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-8628","authenticated-orcid":false,"given":"Qing-Hai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"68970_CR1","doi-asserted-by":"crossref","unstructured":"Molina, J.-M. et al. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. Lancet. HIV 9, e554\u2013e562 (2022).","DOI":"10.1016\/S2352-3018(22)00133-3"},{"key":"68970_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"J-M Molina","year":"2015","unstructured":"Molina, J.-M. et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N. Engl. J. Med. 373, 2237\u20132246 (2015).","journal-title":"N. Engl. J. Med."},{"key":"68970_CR3","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2023.9865","volume":"330","author":"R Chou","year":"2023","unstructured":"Chou, R. et al. Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 330, 746\u2013763 (2023).","journal-title":"JAMA"},{"key":"68970_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme, L. et al. Preexposure prophylaxis for HIV infection among African women. N. Engl. J. Med 367, 411\u2013422 (2012).","journal-title":"N. Engl. J. Med"},{"key":"68970_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1047-1","volume":"16","author":"M Shen","year":"2018","unstructured":"Shen, M., Xiao, Y., Rong, L., Meyers, L. A. & Bellan, S. E. The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco. BMC Med 16, 58 (2018).","journal-title":"BMC Med"},{"key":"68970_CR6","unstructured":"World Health Organization. Closing the gap in a generation: health equity through action on the social determinants of health - Final report of the commission on social determinants of health. https:\/\/www.who.int\/publications\/i\/item\/WHO-IER-CSDH-08.1. (accessed 4 Jul 2025)."},{"key":"68970_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41746-025-01743-7","volume":"8","author":"Z-X Chu","year":"2025","unstructured":"Chu, Z.-X. et al. Real-time digital intervention on oral pre-exposure prophylaxis adherence among MSM: randomized controlled trial. NPJ Digit Med 8, 349 (2025).","journal-title":"NPJ Digit Med"},{"key":"68970_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/QAI.0000000000003601","volume":"98","author":"PA Chan","year":"2025","unstructured":"Chan, P. A. et al. Impact of Social Determinants of Health on Pre-Exposure Prophylaxis Care for HIV Prevention. J. Acquir Immune Defic. Syndr. 98, 465\u2013472 (2025).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"68970_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(12)60821-6","volume":"380","author":"C Beyrer","year":"2012","unstructured":"Beyrer, C. et al. Global epidemiology of HIV infection in men who have sex with men. Lancet 380, 367\u2013377 (2012).","journal-title":"Lancet"},{"key":"68970_CR10","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2352-3018(21)00323-4","volume":"9","author":"TC Poteat","year":"2022","unstructured":"Poteat, T. C. & van der Merwe, L. L. A. Stigma reduction is key to improving the HIV care continuum. Lancet HIV 9, e144\u2013e145 (2022).","journal-title":"Lancet HIV"},{"key":"68970_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2024.100382","volume":"10","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Identifying patterns of sexual behaviors and PrEP uptake characteristics among MSM who were eligible for PrEP: A national cross-section study. J. Virus Erad. 10, 100382 (2024).","journal-title":"J. Virus Erad."},{"key":"68970_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14211-8","volume":"22","author":"A Eubanks","year":"2022","unstructured":"Eubanks, A. et al. Socio-behavioral correlates of pre-exposure prophylaxis use and correct adherence in men who have sex with men in West Africa. BMC Public Health 22, 1832 (2022).","journal-title":"BMC Public Health"},{"key":"68970_CR13","unstructured":"UNAIDS. 2025 Global AIDS Update \u2014 AIDS, Crisis and the Power to Transform. https:\/\/www.unaids.org\/sites\/default\/files\/2025-07\/2025-global-aids-update-JC3153_en.pdf. (accessed 18 Jul 2025)."},{"key":"68970_CR14","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/cid\/ciy810","volume":"68","author":"AY Liu","year":"2019","unstructured":"Liu, A. Y. et al. Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study. Clin. Infect. Dis. 68, 2010\u20132017 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"68970_CR15","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1007\/s10461-020-02901-6","volume":"24","author":"PW Colson","year":"2020","unstructured":"Colson, P. W. et al. Adherence to Pre-exposure Prophylaxis in Black Men Who Have Sex with Men and Transgender Women in a Community Setting in Harlem, NY. AIDS Behav. 24, 3436\u20133455 (2020).","journal-title":"AIDS Behav."},{"key":"68970_CR16","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/S2589-7500(23)00252-2","volume":"6","author":"D Swendeman","year":"2024","unstructured":"Swendeman, D. et al. Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial. Lancet Digital Health 6, e187\u2013e200 (2024).","journal-title":"Lancet Digital Health"},{"key":"68970_CR17","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2352-3018(20)30307-6","volume":"8","author":"JE Haberer","year":"2021","unstructured":"Haberer, J. E. et al. Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial. Lancet HIV 8, e130\u2013e137 (2021).","journal-title":"Lancet HIV"},{"key":"68970_CR18","doi-asserted-by":"publisher","first-page":"e37936","DOI":"10.2196\/37936","volume":"24","author":"B Lin","year":"2022","unstructured":"Lin, B. et al. Effect of a Reminder System on Pre-exposure Prophylaxis Adherence in Men Who Have Sex With Men: Prospective Cohort Study Based on WeChat Intervention. J. Med Internet Res 24, e37936 (2022).","journal-title":"J. Med Internet Res"},{"key":"68970_CR19","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1007\/s10461-023-04050-y","volume":"27","author":"KB Biello","year":"2023","unstructured":"Biello, K. B. et al. PrEPare for Work: A Pilot Randomized Controlled Trial of an Intervention to Optimize HIV PrEP Outcomes Among Male Sex Workers. AIDS Behav. 27, 3294\u20133305 (2023).","journal-title":"AIDS Behav."},{"key":"68970_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jsat.2019.02.006","volume":"100","author":"CJ Reback","year":"2019","unstructured":"Reback, C. J., Fletcher, J. B. & Leibowitz, A. A. Cost Effectiveness of Text Messages to Reduce Methamphetamine Use and HIV Sexual Risk Behaviors among Men who have Sex with Men. J. Subst. Abus. Treat. 100, 59\u201363 (2019).","journal-title":"J. Subst. Abus. Treat."},{"key":"68970_CR21","doi-asserted-by":"publisher","first-page":"e19511","DOI":"10.2196\/19511","volume":"9","author":"K Yun","year":"2021","unstructured":"Yun, K. et al. Mobile Phone Intervention Based on an HIV Risk Prediction Tool for HIV Prevention Among Men Who Have Sex With Men in China: Randomized Controlled Trial. JMIR Mhealth Uhealth 9, e19511 (2021).","journal-title":"JMIR Mhealth Uhealth"},{"key":"68970_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1521\/aeap.2018.30.4.301","volume":"30","author":"P De","year":"2018","unstructured":"De, P., Downing, M. J. & Hirshfield, S. Cost Analysis of Implementing a Video-Based eHealth Intervention for HIV-Positive Gay, Bisexual, and Other Men Who Have Sex With Men. AIDS Educ. Prev. 30, 301\u2013308 (2018).","journal-title":"AIDS Educ. Prev."},{"key":"68970_CR23","unstructured":"World Health Organization. Framework on integrated, people-centred health services (2016). https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/wha69\/a69_39-en.pdf. (accessed 30 Jun 2025)."},{"key":"68970_CR24","unstructured":"World Health Organization. WHO compendium of innovative health technologies for low-resource settings (2024). https:\/\/iris.who.int\/bitstream\/handle\/10665\/378235\/9789240095212-eng.pdf. (accessed 30 Jun 2025)."},{"key":"68970_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(23)02270-5","volume":"403","author":"X Wei","year":"2024","unstructured":"Wei, X. et al. Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial. Lancet 403, 913\u2013923 (2024).","journal-title":"Lancet"},{"key":"68970_CR26","unstructured":"GSM Association. The Mobile Economy Sub-Saharan Africa 2021. https:\/\/tinyurl.com\/yf684tsx. (accessed 2 Jul 2025)."},{"key":"68970_CR27","doi-asserted-by":"publisher","first-page":"ii45","DOI":"10.1093\/oodh\/oqae030","volume":"2","author":"C Kiruthu-Kamamia","year":"2024","unstructured":"Kiruthu-Kamamia, C. et al. Cost-effectiveness analysis of a two-way texting (2wT) intervention to improve ART retention among newly-initiated antiretroviral therapy clients in Malawi. Oxf. Open Digit Health 2, ii45\u2013ii55 (2024).","journal-title":"Oxf. Open Digit Health"},{"key":"68970_CR28","doi-asserted-by":"publisher","first-page":"205520762513498","DOI":"10.1177\/20552076251349890","volume":"11","author":"D Wang","year":"2025","unstructured":"Wang, D., Zhou, Z., Li, M. & Wang, W. Digital health capacity and pediatric care quality in LMICs: A large-scale analysis of 5311 health facilities. Digit Health 11, 20552076251349890 (2025).","journal-title":"Digit Health"},{"key":"68970_CR29","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.12.04094","volume":"12","author":"CY Hui","year":"2022","unstructured":"Hui, C. Y. et al. Mapping national information and communication technology (ICT) infrastructure to the requirements of potential digital health interventions in low- and middle-income countries. J. Glob. Health 12, 04094 (2022).","journal-title":"J. Glob. Health"},{"key":"68970_CR30","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/S2352-3018(15)00016-8","volume":"2","author":"JA Smith","year":"2015","unstructured":"Smith, J. A. et al. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Lancet HIV 2, e159\u2013e168 (2015).","journal-title":"Lancet HIV"},{"key":"68970_CR31","doi-asserted-by":"publisher","first-page":"e0239915","DOI":"10.1371\/journal.pone.0239915","volume":"15","author":"JB Babigumira","year":"2020","unstructured":"Babigumira, J. B. et al. Cost-effectiveness analysis of two-way texting for post-operative follow-up in Zimbabwe\u2019s voluntary medical male circumcision program. PLoS ONE 15, e0239915 (2020).","journal-title":"PLoS ONE"},{"key":"68970_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2025.1391500","volume":"7","author":"OV Awosiku","year":"2025","unstructured":"Awosiku, O. V. et al. Role of digital health technologies in improving health financing and universal health coverage in Sub-Saharan Africa: a comprehensive narrative review. Front Digit Health 7, 1391500 (2025).","journal-title":"Front Digit Health"},{"key":"68970_CR33","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1097\/QAI.0000000000001141","volume":"73","author":"W Chang","year":"2016","unstructured":"Chang, W. et al. Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. J. Acquir Immune Defic. Syndr. 73, e39\u2013e45 (2016).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"68970_CR34","unstructured":"Redmaplebay. What PrEP medications are available in China and what are their costs? https:\/\/mp.weixin.qq.com\/s\/tHj7Xh_EyugcWfrtrw_4BQ. (accessed 2 Jul 2025)."},{"key":"68970_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz, R. J. et al. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N. Engl. J. Med 385, 595\u2013608 (2021).","journal-title":"N. Engl. J. Med"},{"key":"68970_CR36","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"L-G Bekker","year":"2024","unstructured":"Bekker, L.-G. et al. Twice-Yearly Lenacapavir or Daily F\/TAF for HIV Prevention in Cisgender Women. N. Engl. J. Med 391, 1179\u20131192 (2024).","journal-title":"N. Engl. J. Med"},{"key":"68970_CR37","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1016\/S2214-109X(23)00536-3","volume":"12","author":"R Zhao","year":"2024","unstructured":"Zhao, R. et al. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis. Lancet Glob. Health 12, e243\u2013e256 (2024).","journal-title":"Lancet Glob. Health"},{"key":"68970_CR38","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1016\/S2352-3018(24)00239-X","volume":"11","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysis. Lancet HIV 11, e765\u2013e773 (2024).","journal-title":"Lancet HIV"},{"key":"68970_CR39","unstructured":"World Health Organization. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis (2003)."},{"key":"68970_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58120-x","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms. Nat. Commun. 16, 2986 (2025).","journal-title":"Nat. Commun."},{"key":"68970_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04131-w","volume":"23","author":"Z-H Wu","year":"2025","unstructured":"Wu, Z.-H. et al. Cost-effectiveness of self-sampling and enhanced strategies for HPV prevention among men who have sex with men in China: a modeling study. BMC Med 23, 362 (2025).","journal-title":"BMC Med"},{"key":"68970_CR42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10198-021-01384-z","volume":"23","author":"D Cai","year":"2022","unstructured":"Cai, D. et al. Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life. Eur. J. Health Econ. 23, 607\u2013615 (2022).","journal-title":"Eur. J. Health Econ."},{"key":"68970_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12960-017-0200-9","volume":"15","author":"G Seidman","year":"2017","unstructured":"Seidman, G. & Atun, R. Does task shifting yield cost savings and improve efficiency for health systems? A systematic review of evidence from low-income and middle-income countries. Hum. Resour. Health 15, 29 (2017).","journal-title":"Hum. Resour. Health"},{"key":"68970_CR44","doi-asserted-by":"publisher","first-page":"e015654","DOI":"10.1136\/bmjgh-2024-015654","volume":"9","author":"C Kafie","year":"2024","unstructured":"Kafie, C. et al. Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic review. BMJ Glob. Health 9, e015654 (2024).","journal-title":"BMJ Glob. Health"},{"key":"68970_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/QAD.0b013e328321e40b","volume":"23","author":"N Menzies","year":"2009","unstructured":"Menzies, N. et al. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS 23, 395\u2013401 (2009).","journal-title":"AIDS"},{"key":"68970_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.53730\/ijhs.v3nS1.14916","volume":"3","author":"YH Al Shammari","year":"2019","unstructured":"Al Shammari, Y. H. et al. Smart pills: the future of adherence monitoring. Int. J. Health Sci. 3, 1\u201315 (2019).","journal-title":"Int. J. Health Sci."},{"key":"68970_CR47","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41746-025-01722-y","volume":"8","author":"RA El Arab","year":"2025","unstructured":"El Arab, R. A. & Al Moosa, O. A. Systematic review of cost effectiveness and budget impact of artificial intelligence in healthcare. npj Digit. Med. 8, 548 (2025).","journal-title":"npj Digit. Med."},{"key":"68970_CR48","doi-asserted-by":"publisher","first-page":"e2148782","DOI":"10.1001\/jamanetworkopen.2021.48782","volume":"5","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial. JAMA Netw. Open 5, e2148782 (2022).","journal-title":"JAMA Netw. Open"},{"key":"68970_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08709-2","volume":"20","author":"X Jin","year":"2020","unstructured":"Jin, X. et al. Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in China: a multicentre RCT study protocol. BMC Public Health 20, 1160 (2020).","journal-title":"BMC Public Health"},{"key":"68970_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.clinthera.2022.01.011","volume":"44","author":"D Husereau","year":"2022","unstructured":"Husereau, D. et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Clin. Ther. 44, 158\u2013168 (2022).","journal-title":"Clin. Ther."},{"key":"68970_CR51","unstructured":"Centers for Disease control and Prevention. Let\u2019s Stop HlV Together. https:\/\/www.cdc.gov\/stophivtogether\/hiv-prevention\/prep.html. (accessed 24 Jun 2025)."},{"key":"68970_CR52","unstructured":"EASI BANKING. China\u2019s annual per capita GDP data. https:\/\/www.kylc.com\/stats\/global\/yearly_per_country\/g_gdp_per_capita\/chn.html. (accessed 25 Jun 2025)."},{"key":"68970_CR53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W","volume":"6","author":"AH Briggs","year":"1997","unstructured":"Briggs, A. H., Wonderling, D. E. & Mooney, C. Z. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 6, 327\u2013340 (1997).","journal-title":"Health Econ."},{"key":"68970_CR54","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/jama.1986.03370060108029","volume":"255","author":"JP Anderson","year":"1986","unstructured":"Anderson, J. P., Bush, J. W., Chen, M. & Dolenc, D. Policy space areas and properties of benefit-cost\/utility analysis. JAMA 255, 794\u2013795 (1986).","journal-title":"JAMA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68970-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:20:19Z","timestamp":1772461219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68970"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68970-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2106"}}